ClinicalThought

Share

Program Content

Activities

  • PARPi for Prostate Cancer FAQ
    PARP Inhibitors for Prostate Cancer: Expert Answers to Your Questions
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: April 09, 2024

    Expires: April 08, 2025

Faculty

cover img faculity

Daniel P. Petrylak, MD

Professor of Medicine (Medical Oncology) and of Urology
Director, Prostate and GU Medical Oncology
Yale Cancer Center
New Haven, Connecticut

Provided by

ProCE Banner

Supporters

Supported by educational grants from AstraZeneca and Merck & Co., Inc., Rahway, NJ, USA.

AstraZeneca

Merck & Co., Inc., Rahway, NJ, USA